Cargando…

Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk

Human leukocyte antigen (HLA) class I-specific killer-cell immunoglobulin-like receptors (KIR) regulate natural killer (NK) cell function in eliminating malignancy. Breast cancer (BC) patients exhibit reduced NK-cytotoxicity in peripheral blood. To test the hypothesis that certain KIR-HLA combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashouri, Elham, Rajalingam, Karan, Barani, Shaghik, Farjadian, Shirin, Ghaderi, Abbas, Rajalingam, Raja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041876/ https://www.ncbi.nlm.nih.gov/pubmed/33846431 http://dx.doi.org/10.1038/s41598-021-86964-y

Ejemplares similares

KIR-HLA gene diversities and susceptibility to lung cancer
por: Hematian Larki, Marjan, et al.
Publicado: (2022)

KIR gene content diversity in four Iranian populations
por: Ashouri, Elham, et al.
Publicado: (2009)

Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19
por: Maruthamuthu, Stalinraja, et al.
Publicado: (2022)

The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection
por: Rajalingam, Raja
Publicado: (2016)

Human diversity of killer cell immunoglobulin-like receptors and disease
por: Rajalingam, Raja
Publicado: (2011)

Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients
por: Mirzazadeh, Sara, et al.
Publicado: (2023)

Killer Cell Immunoglobulin-Like Receptors (KIRs) Genotype and Haplotype Analysis in Iranians with Non-Melanoma Skin Cancers
por: Yousefinejad, Fahimeh, et al.
Publicado: (2019)

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease
por: Levinson, Ralph D., et al.
Publicado: (2016)

Allele-level HLA matching reduces early rejection in lung transplant recipients
por: Rajalingam, Raja
Publicado: (2020)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer
por: Farjadian, Shirin, et al.
Publicado: (2018)

NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80
Publicado: (1994)

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
Publicado: (1995)

Prevalence of camel babesiosis in southeast of Iran
por: Mirahmadi, Hadi, et al.
Publicado: (2021)

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
por: Wang, Ruihua, et al.
Publicado: (2023)

Human-Specific Evolution and Adaptation Led to Major Qualitative Differences in the Variable Receptors of Human and Chimpanzee Natural Killer Cells
por: Abi-Rached, Laurent, et al.
Publicado: (2010)

Behçet’s disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I
por: Kuranov, Alexandr Borisovich, et al.
Publicado: (2014)

A Killer Immunoglobulin - Like Receptor Gene - Content Haplotype and A Cognate Human Leukocyte Antigen Ligand are Associated with Autism
por: Torres, Anthony, et al.
Publicado: (2016)

COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates
por: Roll, Garrett R., et al.
Publicado: (2021)

Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease
por: Ayo, Christiane Maria, et al.
Publicado: (2015)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

Scientific opinion on Prosmoke BW 01
por: Younes, Maged, et al.
Publicado: (2022)

A Rare Case of Hansen’s Disease Complicated by G6PD Deficiency
por: Yerke Hansen, Payton, et al.
Publicado: (2023)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
por: Nowak, Izabela, et al.
Publicado: (2012)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
por: Tuttolomondo, Antonino, et al.
Publicado: (2019)

Paternal HLA-C and Maternal Killer-Cell Immunoglobulin-Like Receptor Genotypes in the Development of Autism
por: Gamliel, Moriya, et al.
Publicado: (2016)

Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases
por: Beigmohammadi, Fereshteh, et al.
Publicado: (2020)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
por: Cardozo, Daniela Maira, et al.
Publicado: (2023)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation
por: Faridi, Rehan Mujeeb, et al.
Publicado: (2016)

Activating KIR and HLA Bw4 Ligands Are Associated to Decreased Susceptibility to Pemphigus Foliaceus, an Autoimmune Blistering Skin Disease
por: Augusto, Danillo G., et al.
Publicado: (2012)

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma
por: Sun, Haibo, et al.
Publicado: (2021)

CT chest – A rapid screening tool in COVID-19 pandemic
por: Rajalingam, Bavaharan
Publicado: (2021)

SAP BW: a step-by-step guide
por: Fu, Henry, et al.
Publicado: (2003)

Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2019)

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2009)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population
por: Nakimuli, Annettee, et al.
Publicado: (2013)

Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis
por: Littera, Roberto, et al.
Publicado: (2016)

Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control
por: Malnati, Mauro S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_abkvcl16018vsb2e30rrgjupra